NL-OMON28080招募中不适用

Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: a multiple baseline case series study testing cognitive-behavioral and experiential interventions.

Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Inclusion criteria are a primary diagnosis of DSM-IV and/or DSM-5 autism spectrum disorder and personality disorder, age 18-65 years, with IQ at least normal intelligent (IQ > 80), at least a completed primary school and secondary education, having a reasonable degree of insight into their own personality and recognition of their (psychological) functioning, and a willingness to participate in the study for 2 years confirmed by a signed informed consent.

•Exclusion criteria are schizophrenia or other psychotic disorder, antisocial PD, eating disorder, psychiatric disorders secondary to medical conditions, mental retardation (IQ < 80), addiction (that needs clinical detox) and presence of current suicidal ideation. Participants are not allowed to follow another concurrent psychological treatment at the same time. Pharmacotherapy can be used as a co-intervention during the treatment when already started before the study intervention. This is no reason for exclusion from the study. When participants have to start with pharmacotherapy or another form of (support) therapy during the study intervention, for example in case of acute crisis, this will not lead to exclusion from the study, only when this therapy and the results will be documented precisely.

发起方

Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands